Profile data is unavailable for this security.
About the company
WntResearch AB is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process. As of December 31, 2011, the Company had two projects, namely Foxy-5 and Box-5. Foxy-5 is a hexapeptide mimicking the effects of WNT-5a. Box-5 is a peptide antagonizing the effects of Wnt-5a. As of March 31, 2012, the Company’s largest shareholder was Forskarpatent I Syd AB, which held 26.55% shares.
- Revenue in SEK (TTM)0.00
- Net income in SEK-32.47m
- Incorporated2007
- Employees2.00
- LocationWntresearch ABc/o Er Redovisning, Stora Sodergatan 15LUND 222 23SwedenSWE
- Phone+46 40321022
- Websitehttps://www.wntresearch.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combigene AB | 5.54m | -35.67m | 72.27m | 8.00 | -- | 0.6206 | -- | 13.04 | -1.80 | -1.80 | 0.28 | 5.88 | 0.0398 | -- | 2.63 | 693,015.00 | -25.58 | -13.00 | -26.56 | -14.58 | -- | -- | -643.32 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
| Abera Bioscience AB | 0.00 | -16.72m | 72.31m | -- | -- | 12.04 | -- | -- | -1.24 | -1.24 | 0.00 | 0.391 | 0.00 | -- | -- | -- | -115.63 | -79.43 | -149.06 | -96.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.73 | -- | -- | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -27.75m | 77.47m | -- | -- | 0.2232 | -- | -- | -0.0984 | -0.0984 | 0.00 | 0.6946 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -13.84 | -- |
| Bioextrax AB publ | 2.06m | -21.51m | 80.45m | -- | -- | 3.35 | -- | 39.11 | -0.8026 | -0.8026 | 0.0769 | 0.6968 | 0.0681 | -- | 124.67 | -- | -71.18 | -86.39 | -82.24 | -110.84 | 34.95 | -- | -1,045.55 | -2,119.90 | -- | -- | -- | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
| Spago Nanomedical AB (publ) | 1.20m | -42.22m | 82.70m | 13.00 | -- | 1.96 | -- | 68.74 | -0.3818 | -0.3818 | 0.0115 | 0.1882 | 0.0093 | -- | 5.74 | 92,538.46 | -32.61 | -20.19 | -35.38 | -20.97 | 247.55 | -- | -3,509.81 | -4,853.45 | -- | -- | -- | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Odi Pharma AB (publ) | 818.38k | -3.97m | 86.75m | -- | -- | 42.61 | -- | 106.01 | -0.2608 | -0.2608 | 0.0538 | 0.1338 | 0.1084 | 1.22 | 6.98 | -- | -52.58 | -- | -95.24 | -- | -53.07 | -- | -484.96 | -- | 1.32 | -14.10 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
| AroCell AB (publ) | 43.04m | -59.30m | 91.22m | -- | -- | 0.5574 | -- | 2.12 | -0.2574 | -0.2574 | 0.1868 | 0.7104 | 0.2095 | 6.68 | 6.52 | -- | -28.86 | -29.25 | -30.70 | -31.37 | -4.38 | -9.85 | -137.78 | -231.19 | 5.25 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
| Biosergen AB | 0.00 | -27.04m | 91.59m | 3.00 | -- | 7.90 | -- | -- | -0.4007 | -0.4007 | 0.00 | 0.0418 | 0.00 | -- | -- | 0.00 | -131.31 | -- | -217.09 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.25 | -- | -- | -- |
| Immunovia AB (publ) | 1.58m | -309.44m | 91.93m | 11.00 | -- | 1.37 | -- | 58.37 | -8.27 | -8.27 | 0.0412 | 1.48 | 0.0079 | 74.81 | 7.89 | 143,181.80 | -155.00 | -41.33 | -179.24 | -44.24 | -4,687.68 | -7,553.76 | -19,646.92 | -20,879.26 | 2.69 | -22.84 | 0.1329 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| Wntresearch AB | 0.00 | -32.47m | 92.24m | 2.00 | -- | 1.75 | -- | -- | -0.1108 | -0.1108 | 0.00 | 0.0609 | 0.00 | -- | -- | 0.00 | -134.85 | -100.71 | -166.68 | -123.59 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -5.65 | -- | -- | -- |
| Sprint Bioscience AB | 50.49m | -441.00k | 92.86m | 28.00 | -- | 3.34 | 13,265.82 | 1.84 | -0.0064 | -0.0064 | 0.7232 | 0.3978 | 1.01 | -- | 7.58 | 1,803,036.00 | -0.8838 | -71.22 | -1.58 | -113.71 | 82.77 | 62.75 | -0.8735 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Ziccum AB | 3.75m | -21.41m | 93.46m | 8.00 | -- | 9.82 | -- | 24.94 | -1.54 | -1.54 | 0.2701 | 0.6191 | 0.1553 | -- | 2.01 | 468,375.00 | -88.74 | -68.51 | -109.73 | -76.47 | -- | -- | -571.44 | -2,598.03 | -- | -- | 0.0908 | -- | -- | 75.20 | 25.62 | -- | -13.45 | -- |
| Dextech Medical AB | 0.00 | -4.57m | 94.28m | 1.00 | -- | 2.92 | -- | -- | -0.2473 | -0.2473 | 0.00 | 1.75 | 0.00 | -- | -- | -- | -13.04 | -28.96 | -13.21 | -29.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.89 | -- | 0.412 | -- |
| Toleranzia AB | 0.00 | -7.46m | 102.08m | -- | -- | 0.665 | -- | -- | -0.0597 | -0.0597 | 0.00 | 0.779 | 0.00 | -- | -- | -- | -5.21 | -7.45 | -5.43 | -7.78 | -- | -- | -- | -- | -- | -- | 0.0055 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -46.41m | 103.98m | 4.00 | -- | 16.39 | -- | -- | -0.1887 | -0.1887 | 0.00 | 0.0183 | 0.00 | -- | -- | 0.00 | -256.08 | -125.42 | -351.79 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Opticept Technologies AB | 9.15m | -80.36m | 105.51m | 29.00 | -- | 0.2314 | -- | 11.54 | -2.62 | -2.62 | 0.2981 | 10.80 | 0.0213 | -0.0638 | 2.37 | 315,344.80 | -18.69 | -41.76 | -21.19 | -46.21 | 125.88 | 62.65 | -879.63 | -882.41 | 0.6163 | -14.16 | 0.0566 | -- | -12.90 | 49.17 | 19.80 | -- | 45.22 | -- |
Data as of Apr 30 2024. Currency figures normalised to Wntresearch AB's reporting currency: Swedish Krona SEK
